Molecular Diagnostics Market Size to Hit USD 30.9 billion by 2035 | Exclusive Report by Roots Analysis
The Molecular Diagnostics Market size was valued at USD 15.9 billion in 2024 and estimated to grow at a CAGR of 6.2% during the forecast period 2024 to 2035
Molecular diagnostic tests are diagnostic tests that use genetic samples, such as DNA and RNA to detect genetic mutations, pathogens and various diseases. Such tests help diagnose, monitor, and manage diseases, such as genetic diseases, infectious diseases, and oncological disorders.
The common types of molecular diagnostic tests include PCR, RT-PCR, DNA microarrays and next generation sequencing. Such tests play a crucial role in healthcare by providing timely and accurate information for medical decision-making. Molecular diagnostic solutions are essential tools for screening, diagnosing, and monitoring diseases, ultimately contributing to improved patient outcomes and public health.
According to Roots Analysis, the molecular diagnostics market size was valued at USD 15.9 billion in 2024 and likely to hit over USD 30.9 billion by 2035, growing at a CAGR of 6.2% during the forecast period 2024 to 2035
By test type, the laboratory testing segment is expected to account for the largest share of the global molecular diagnostics market
It is worth mentioning that the point-of-care testing segment is expected to grow at a higher CAGR compared to laboratory testing market owing to their ability to deliver rapid test results and offer improved convenience and accessibility.
By type of offering, reagents hold a significant market share during the forecast period
The large share of reagents in the molecular diagnostics market is likely due to the fact that the reagents are required to be replenished frequently, thus generating a recurring stream of revenue for the companies.
By sample type, the blood, serum and plasma segment is expected to account for the largest share of the global molecular diagnostics market
It is worth mentioning that the urine sample segment is expected to grow at a higher CAGR compared to the market for other samples owing to their involvement in a number of infectious diseases and genetic diseases.
By type of technology, the PCR segment led the global molecular diagnostics market
The PCR segment occupies the highest share (41%) in 2024 and is expected to witness substantial growth during the forecast period. This is followed by next generation sequencing segment which occupies the second largest molecular diagnostics market share.
By therapeutic areas, infectious disease segment is anticipated to capture the largest share of the global molecular diagnostics market
The market growth of the molecular diagnostics market is expected to be driven by the increasing prevalence of chronic disorders, leading to a CAGR of 6.2% over the forecast period. In terms of therapeutic areas, molecular diagnostic solutions intended for infectious diseases currently capture the majority (42.8%) of the market share.
By end users, hospitals segment is anticipated to capture the largest share of the global molecular diagnostics market
Hospitals are expected to hold the majority molecular diagnostics market share (48%) in 2024 and this trend is expected to continue till 2035, whereas the laboratories segment is expected to grow at the highest growth rate of 6.5%, compared to other segments.
Molecular Diagnostics Market Regional Analysis
North America is expected to dominate the molecular diagnostics market. In recent years, technological advancements have resulted in a tremendous increase in the adoption of molecular diagnostic solutions across various healthcare settings. This indicates that North America plays a significant role in the global molecular diagnostics market and showcases the need for companies to focus on this region in order to capitalize on the growing demand for molecular diagnostic solutions.
Asia is a key region for the with countries like China, Japan, South Korea, and India playing a central role. It is worth highlighting that, in the coming years, owing to the anticipated increase in the demand for molecular diagnostic solutions, the market in Asia is likely to grow at a healthy CAGR during the forecast period.
Key Market Players
Abbott Laboratories, Agilent Technologies, Becton Dickinson, BGI Genomics, bioMrieux, Bio-Rad, Danaher, DiaSorin, Grifols, Hologic, Illumina, Qiagen, QuidelOrtho, Revvity, Roche, Sansure, Seegene, Siemens Healthineers, Sysmex, Thermo Fisher Scientific
Key Segments:
by Test Type
Laboratory Testing
Point-of-Care Testing
by Type of Offering
Reagents
Instruments
Services
by Type of Sample
Blood, Serum and Plasma
Urine
Others
by Type of Technology
PCR
In situ Hybridization
Isothermal Nucleic Acid Amplification Technology
Next Generation Sequencing
Microarrays
Mass Spectrometry
Others
by Therapeutic Area
Cardiovascular Diseases
Genetic Diseases
Infectious Diseases
Neurological Disease
Oncological Disorders
Others
by End Users
Hospitals
Laboratories
Others
by Geographical Regions
North America
Europe
Asia
Latin America
Middle East and North Africa
Rest of the World
About Roots Analysis
Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
Contact Details
Gaurav Chaudhary
+1 (857) 387 7999
+44 (748) 188 1310
Email: sales@rootsanalysis.com
